Novartis Aims for Major M&A

Novartis, the Swiss pharmaceutical giant, anticipates significant growth from large-scale merger and acquisition (M&A) activities. The company’s CEO, Vas Narasimhan, recently underscored the firm's strategic readiness to leverage substantial M&A...